HighTower Advisors LLC Has $1.27 Million Position in Lincoln National Corporation $LNC

HighTower Advisors LLC boosted its holdings in shares of Lincoln National Corporation (NYSE:LNC) by 7.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,452 shares of the financial services provider’s stock after buying an additional 2,608 shares during the period. HighTower Advisors LLC’s holdings in Lincoln National were worth $1,273,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of LNC. Mariner LLC boosted its stake in Lincoln National by 2.0% during the fourth quarter. Mariner LLC now owns 28,934 shares of the financial services provider’s stock worth $917,000 after buying an additional 581 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Lincoln National by 2.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,876,319 shares of the financial services provider’s stock valued at $91,208,000 after purchasing an additional 56,614 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Lincoln National by 11.4% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 100,774 shares of the financial services provider’s stock valued at $3,196,000 after purchasing an additional 10,327 shares in the last quarter. Voya Investment Management LLC boosted its stake in shares of Lincoln National by 68.8% in the 4th quarter. Voya Investment Management LLC now owns 102,379 shares of the financial services provider’s stock valued at $3,246,000 after purchasing an additional 41,736 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in shares of Lincoln National in the 4th quarter valued at $9,132,000. Institutional investors and hedge funds own 72.81% of the company’s stock.

Lincoln National Stock Performance

Shares of NYSE:LNC opened at $41.90 on Tuesday. The stock has a market capitalization of $7.94 billion, a P/E ratio of 7.31, a P/E/G ratio of 0.58 and a beta of 1.42. Lincoln National Corporation has a 1-year low of $27.58 and a 1-year high of $42.36. The company has a current ratio of 0.26, a quick ratio of 0.26 and a debt-to-equity ratio of 0.67. The business has a 50-day moving average price of $36.17 and a two-hundred day moving average price of $34.94.

Lincoln National (NYSE:LNC) last announced its quarterly earnings data on Thursday, July 31st. The financial services provider reported $2.36 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.45. The firm had revenue of $4.04 billion during the quarter, compared to analysts’ expectations of $4.65 billion. Lincoln National had a return on equity of 19.14% and a net margin of 6.34%.During the same period in the previous year, the business posted $1.87 EPS. Equities analysts predict that Lincoln National Corporation will post 7.69 earnings per share for the current year.

Lincoln National Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Friday, October 10th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 4.3%. The ex-dividend date of this dividend is Friday, October 10th. Lincoln National’s payout ratio is currently 31.41%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on LNC shares. Wall Street Zen upgraded shares of Lincoln National from a “sell” rating to a “hold” rating in a research note on Saturday, August 2nd. Barclays lifted their price target on Lincoln National from $38.00 to $40.00 and gave the company an “equal weight” rating in a report on Friday, May 9th. Keefe, Bruyette & Woods upped their price target on shares of Lincoln National from $40.00 to $42.00 and gave the stock a “market perform” rating in a research report on Monday, August 4th. Piper Sandler reduced their price target on shares of Lincoln National from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Friday, May 9th. Finally, Cfra Research upgraded shares of Lincoln National to a “hold” rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $39.70.

Insider Activity

In other Lincoln National news, EVP John Christopher Kennedy sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $39.29, for a total transaction of $196,450.00. Following the completion of the sale, the executive vice president directly owned 123,815 shares of the company’s stock, valued at approximately $4,864,691.35. The trade was a 3.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Brian Kroll sold 10,075 shares of the business’s stock in a transaction dated Thursday, May 29th. The stock was sold at an average price of $33.10, for a total value of $333,482.50. Following the sale, the executive vice president directly owned 48,743 shares of the company’s stock, valued at $1,613,393.30. This represents a 17.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.54% of the company’s stock.

Lincoln National Profile

Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates in four segments: Life Insurance, Annuities, Group Protection, and Retirement Plan Services. The Life Insurance segment provides life insurance products, including term insurance, universal life insurance (UL), indexed universal life insurance, variable universal life insurance (VUL), linked-benefit UL and VUL products, and critical illness and long-term care riders.